Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Comment: COVID has exposed the need for flexible global data access


At a time when the work of disease modellers has been thrust into the spotlight, DPUK’s director, Professor John Gallacher, comments on the important role of technology platforms which democratise access to global health data.

Dementia Ecosystem UK: action through alliance

General Research

One in three people born today will develop dementia in their lifetime: it's the biggest health challenge of our generation. With one million people predicted to have dementia by 2025 in the UK, and a current cost of £26bn a year to the UK economy, there is huge financial and societal impact, yet we’re still without treatment.

Cohorts invited to join dementia trials register

General Impact Research Trials

DPUK has launched Great Minds, an innovative new register of volunteers for clinical trials who bring rich data from their previous health studies to help clear the deadlock in development of treatments for dementia.

Datathon for dementia

General Research

Data scientists from many different backgrounds combined their expertise to take on dementia in an unusual format for disease research: a three-day datathon. The intensive research event saw teams come together to work on data that is now available in the DPUK Data Portal.

DPUK approach attracts interest from beyond dementia sector


Thanks to leaps forward in computing power, DPUK is able to harness highly advanced technical solutions to maintain data security and non-identifiability of millions of existing health records in the Data Portal. It’s a model that is globally unique for dementia research and one that’s increasingly attracting attention from other sectors.

Why volunteer health data will accelerate the development of treatments for dementia


Thanks to the generosity of two million health studies volunteers, there is new hope for accelerating the discovery of treatments for dementia. Their combined data – lifestyle, genes, memory tests, and brain scans – are helping researchers identify changes over time which will reveal how dementia starts in healthy brains.

New partner announcement: Cambridge Cognition

General Research

Dementias Platform UK continues to expand as Cambridge Cognition, a global leader in cognitive assessment for clinical trials, upgrades its current position as associate partner to become full partner.

A step forward for dementia studies: body-worn sensors to assess how we walk

General Publication Research

Body-worn sensors used by people with mild Alzheimer’s to assess walking could offer a cost-effective way to detect the disease early and monitor its progression.